GENETIC CHEMISTRY Trademark

Trademark Overview

On Friday, December 22, 2023, a trademark application was filed for GENETIC CHEMISTRY with the United States Patent and Trademark Office. The USPTO has given the GENETIC CHEMISTRY trademark a serial number of 98327493. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, February 15, 2025. This trademark is owned by Empress Therapeutics, Inc.. The GENETIC CHEMISTRY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals, namely, pharmaceutical preparations for treatment of cancer, inflammatory diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; therapeutics in the nature of oral products, injectables, topical products, inhalation products, ophthalmic products, otic products, nasal products, rectal products, vaginal products, implants, infusions, transdermal systems, and oral thin films; therapeutic pharmaceuticals for the treatment of cancer, inflammatory diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders

Pharmaceutical research and development; scientific and medical research and development; technical scientific research consultation and product development for others in the field of biotechnology and the development of pharmaceuticals and microbial products; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; drug discovery platform
genetic chemistry

General Information

Serial Number98327493
Word MarkGENETIC CHEMISTRY
Filing DateFriday, December 22, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, February 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceuticals, namely, pharmaceutical preparations for treatment of cancer, inflammatory diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; therapeutics in the nature of oral products, injectables, topical products, inhalation products, ophthalmic products, otic products, nasal products, rectal products, vaginal products, implants, infusions, transdermal systems, and oral thin films; therapeutic pharmaceuticals for the treatment of cancer, inflammatory diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
Goods and ServicesPharmaceutical research and development; scientific and medical research and development; technical scientific research consultation and product development for others in the field of biotechnology and the development of pharmaceuticals and microbial products; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; drug discovery platform

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 3, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 28, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmpress Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Friday, December 22, 2023NEW APPLICATION ENTERED
Thursday, April 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 24, 2024ASSIGNED TO EXAMINER
Sunday, July 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, July 28, 2024NON-FINAL ACTION E-MAILED
Sunday, July 28, 2024NON-FINAL ACTION WRITTEN
Monday, October 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 30, 2024FINAL REFUSAL E-MAILED
Wednesday, October 30, 2024FINAL REFUSAL WRITTEN
Wednesday, October 30, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, February 15, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, February 15, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Related Keywords

chemistry genetic disorders diseases products development research pharmaceuticals microbial biotechnology field oral